CDI: Healthcare Facts and Statistics

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 178 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Clostridioides difficile Infection (CDI): Overview, Laboratory Tests and Updated Guidelines. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Clostridioides difficile Infection (CDI): Overview, Laboratory Tests and Updated Guidelines (online CE course)
CDI: Healthcare Facts and Statistics

The following is a summary of the healthcare-related facts and statistics on CDI:
  • C diff bacterium is ubiquitous in nature and especially prevalent in soil. In 2-5% of the adult population, the bacterium may become established in the human colon. C diff can be transmitted from person to person by the fecal-oral route.
  • Annually in the U.S., approximately a half million individuals become ill from the C diff bacteria and an estimated 29,000 deaths occur within 30 days of the initial diagnosis. In recent years in the U.S. and other countries, C diff infections (CDIs) have become more frequent, severe, and difficult to treat. CDI is now the most common cause of diarrhea in people who develop diarrheal symptoms while hospitalized.
  • CDI differs from most other infections because it typically occurs after treatment with antibiotics. With the increased use of antibiotics, the incidence of CDI has increased over the past two decades and now makes up about 20% of antibiotic-associated diarrhea. It is estimated that CDI costs the United States healthcare system $5 billion every year.
  • CDI is a global problem occurring in all areas of the world. Rates of infection globally have increased over the past several years. It appears that women are more often affected than men.
  • The increased incidence and severity of CDI observed in the U.S. and other countries have been attributed to the emergence of a new strain (strain 027) of Clostridiodes difficile, which appears to be more virulent than other strains.